Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism

被引:67
作者
Kocovska, Eva [1 ]
Gaughran, Fiona [2 ]
Krivoy, Amir [2 ]
Meier, Ute-Christiane [3 ]
机构
[1] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England
[2] Kings Coll London, Dept Psychosis Studies, South London & Maudlsey NHS Fdn Trust, Inst Psychiat Psychol & Neurosci,Natl Psychosis S, London, England
[3] Queen Mary Univ London, Neuroinflammat & Psychoimmunol Grp, Dept Neurosci & Trauma, Barts & London Sch Med & Dent,Blizard Inst, London, England
关键词
vitamin-D; multiple sclerosis; schizophrenia; autism; immunity; microbiome; EPSTEIN-BARR-VIRUS; CENTRAL-NERVOUS-SYSTEM; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; SPECTRUM DISORDER; D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; IMMUNE ACTIVATION; SEX-DIFFERENCES; YOUNG-ADULTS;
D O I
10.3389/fpsyt.2017.00047
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In this short review, we want to summarize the current findings on the role of vitamin-D in multiple sclerosis (MS), schizophrenia, and autism. Many studies have highlighted hypo-vitaminosis-D as a potential environmental risk factor for a variety of conditions such as MS, asthma, cardiovascular disease, and, more recently, psychiatric diseases. However, whether hypovitaminosis-D is a potential causative factor for the development or activity in these conditions or whether hypovitaminosis-D may be due to increased vitamin-D consumption by an activated immune system (reverse causation) is the focus of intense research. Here, we will discuss current evidence exploring the role of vitamin-D in MS, schizophrenia, and autism and its impact on adaptive and innate immunity, antimicrobial defense, the microbiome, neuroinflammation, behavior, and neurogenesis. More work is needed to gain insight into its role in the underlying pathophysiology of these conditions as it may offer attractive means of intervention and prevention.
引用
收藏
页数:11
相关论文
共 133 条
[1]   Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci [J].
Andreassen, O. A. ;
Harbo, H. F. ;
Wang, Y. ;
Thompson, W. K. ;
Schork, A. J. ;
Mattingsdal, M. ;
Zuber, V. ;
Bettella, F. ;
Ripke, S. ;
Kelsoe, J. R. ;
Kendler, K. S. ;
O'Donovan, M. C. ;
Sklar, P. ;
McEvoy, L. K. ;
Desikan, R. S. ;
Lie, B. A. ;
Djurovic, S. ;
Dale, A. M. .
MOLECULAR PSYCHIATRY, 2015, 20 (02) :207-214
[2]   Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression [J].
Ascherio, Alberto ;
Munger, Kassandra L. ;
White, Rick ;
Koechert, Karl ;
Simon, Kelly Claire ;
Polman, Chris H. ;
Freedman, Mark S. ;
Hartung, Hans-Peter ;
Miller, David H. ;
Montalban, Xavier ;
Edan, Gilles ;
Barkhof, Frederik ;
Pleimes, Dirk ;
Radue, Ernst-Wilhelm ;
Sandbrink, Rupert ;
Kappos, Ludwig ;
Pohl, Christoph .
JAMA NEUROLOGY, 2014, 71 (03) :306-314
[3]   Vitamin D: modulator of the immune system [J].
Baeke, Femke ;
Takiishi, Tatiana ;
Korf, Hannelie ;
Gysemans, Conny ;
Mathieu, Chantal .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) :482-496
[4]   Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 [J].
Bahlo, Melanie ;
Booth, David R. ;
Broadley, Simon A. ;
Brown, Matthew A. ;
Foote, Simon J. ;
Griffiths, Lyn R. ;
Kilpatrick, Trevor J. ;
Lechner-Scott, Jeanette ;
Moscato, Pablo ;
Perreau, Victoria M. ;
Rubio, Justin P. ;
Scott, Rodney J. ;
Stankovich, Jim ;
Stewart, Graeme J. ;
Taylor, Bruce V. ;
Wiley, James ;
Clarke, Glynnis ;
Cox, Mathew B. ;
Csurhes, Peter A. ;
Danoy, Patrick ;
Drysdale, Karen ;
Field, Judith ;
Foote, Simon J. ;
Greer, Judith M. ;
Guru, Preethi ;
Hadler, Johanna ;
McMorran, Brendan J. ;
Jensen, Cathy J. ;
Johnson, Laura J. ;
McCallum, Ruth ;
Merriman, Marilyn ;
Merriman, Tony ;
Pryce, Karen ;
Tajouri, Lotfi ;
Wilkins, Ella J. ;
Browning, Brian L. ;
Browning, Sharon R. ;
Perera, Devindri ;
Butzkueven, Helmut ;
Carroll, William M. ;
Chapman, Caron ;
Kermode, Allan G. ;
Marriott, Mark ;
Mason, Deborah ;
Heard, Robert N. ;
Pender, Michael P. ;
Slee, Mark ;
Tubridy, Niall ;
Willoughby, Ernest .
NATURE GENETICS, 2009, 41 (07) :824-U84
[5]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[6]   Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation [J].
Bartels, Lars E. ;
Hvas, Christian L. ;
Agnholt, Jorgen ;
Dahlerup, Jens F. ;
Agger, Ralf .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (08) :922-928
[8]   Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments [J].
Bell, MD ;
Mishara, AL .
SCHIZOPHRENIA RESEARCH, 2006, 81 (01) :17-27
[9]   Commensal gut flora and brain autoimmunity: a love or hate affair? [J].
Berer, Kerstin ;
Krishnamoorthy, Gurumoorthy .
ACTA NEUROPATHOLOGICA, 2012, 123 (05) :639-651
[10]  
BHALLA AK, 1984, J IMMUNOL, V133, P1748